Sagimet Biosciences
CA - San MateoBiotechnology
Focus: Sagimet Biosciences is a clinical-stage biotech focused on fatty acid synthase (FAS) inhibitors targeting metabolic diseases, oncology, and infectious diseases. The company is publicly traded and headquartered in San Mateo, CA.
Profile data last refreshed 17h ago · AI intelligence enriched 3w ago
Open Jobs
5+3 this month
Stable — net +3 jobs in 30d
4 added, 1 removed. Backfill posture.
Should You Work at Sagimet Biosciences?
AI assessmentBest fit for specialists (regulatory, clinical ops) seeking a focused platform bet in metabolic disease with near-term Phase 3 catalysts; less suitable for growth-phase generalists.
Why Work Here
- Lead a focused, mechanism-driven platform with 12 active trials across three therapeutic areas, providing exposure to oncology and metabolic disease simultaneously.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Denifanstat
HealthyClinical Trials (1)
NCT07216313A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants
Phase 1Help build intelligence for Sagimet Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.